Science for Organizations: Analysis. Insight. Understanding. Science For Organizations . 75 DeSilva Island Drive . Mill Valley, CA 94941 . Phone 415-381-1041 . Fax 415-381-1046 . Email: info@scifororg.com
HOME ABOUT CASE STUDIES CLIENTS TESTIMONIALS BIBLIOGRAPHY CONTACT

355 Gardner JD. Triadafilopoulos G. Identifying different phenotypes of symptomatic gastroesophageal reflux disease using artificial intelligence. medRxiv April, 2023.
354 Gardner JD. Gastric acidity in different phenotypes of symptomatic gastroesophageal reflux disease. medRxiv April, 2023.
353 Gardner JD. Decreased variation in esophageal acid concentration in different phenotypes of symptomatic gastroesophageal reflux disease. medRxiv April, 2023.
352 Gardner, J. D. Oscillating esophageal acid sensitivity in symptomatic reflux hypersensitivity and functional heartburn. https://doi.org/10.32388/ IJUE1J.2.
351 Gardner J.D., Sloan S., Robinson M., Miner P.B. The relationship between esophageal acidity and symptom frequency in symptomatic nonerosive gastroesophageal reflux disease Physiological Reports, 10, e15442. https://doi.org/10.14814/phy2.15442
350 Mengyu Zhang1,5; Busra Yaman1; Sabine Roman2; Edoardo Savarino3; C. Prakash Gyawali4; Jerry D. Gardner6; Daniel Sifrim1 Post-reflux swallow-induced peristaltic wave (PSPW): physiology, triggering factors and role in reflux clearance in healthy subjects
349 Sonu I, Triadafilopoulos G, Gardner JD. Persistent constipation and abdominal adverse events with newer treatments for constipation. BMJ Open Gastro 2016; 3:e000094.
348 Lu L, Mu JC, Sloan S, Miner Jr. PB, Gardner JD. Exploring the physiologic role of human gastroesophageal reflux by analyzing time-series data from 24-hr gastric and esophageal pH recordings. Physiological Reports 2, e12051, 2014.
347 Gardner, J.D. Increased gastric acid secretion as a possible cause of GERD. Nature Reviews Gastroenterology & Hepatology 7:125-126, 2010.
346 Blondeau, K., Sifrim, D., Gardner, J.D. Continuous distal oesophageal acidification decreases postprandial gastric acidity in healthy human subjects. Aliment Pharmacol Ther 29:561-570, 2009.
345 Gerson L., Triadafilopoulos G., Sahbaie P., Young W., Sloan S., Robinson M., Miner P.B. Jr. and Gardner J.D. Time esophageal pH < 4 overestimates the prevalence of pathologic esophageal reflux in subjects with gastroesophageal reflux disease treated with proton pump inhibitors. BMC Gastroenterology 8:15-26, 2008
344 Gardner J.D. How do I interpret a positive diagnostic test? Gastrointestinal Endoscopy 66: 891-893, 2007.
343 Gardner J.D., Young W., Sloan S., Robinson M., Miner P.B. Jr. The effects of changing temperature correction factors on measures of acidity calculated from gastric and oesophageal pH recordings. Aliment Pharmacol Ther 23:629-638, 2006.
342 Gardner J.D., Young W., Sloan S., Robinson M., Miner P.B. Jr. The fractal nature of human gastro-oesophageal disease. Aliment Pharmacol Ther 22:823-830, 2005.
341 Gardner J.D., Sloan S., Robinson M., Miner P.B. Frequency analyses of gastric pH in control and gastro-oesophageal reflux disease subjects treated with a proton-pump inhibitor. Aliment Pharmacol Ther 20:1381-1386, 2004.
340 Gardner J.D., Sloan S., Robinson M., Miner P.B. Oesophageal pH has a power-law distribution in control and gastro-oesophageal reflux disease subjects. Aliment Pharmacol Ther 20:1373-1379, 2004.
339 Gardner J.D., Gallo-Torres H., Sloan S., Robinson M., Miner P.B. Jr. The basis for the decreased response to proton pump inhibitors in gastro-oesophageal reflux disease patients without erosive oesophagitis. Aliment Pharmacol Ther 18:891-905, 2003.
338 Gardner J.D., Sloan S., Robinson M., Miner P.B. Jr. Heartburn severity can predict pathologic oesophageal reflux in gastro-oesophageal reflux patients treated with a proton pump inhibitor. Aliment Pharmacol Ther 18:133-140, 2003.
337 Gardner, J.D., Sloan, S., Miner, P.B. Jr., Robinson, M. Determination of the reduction in gastric acidity necessary to prevent pathological oesophageal reflux in patients with gastroesophageal reflux disease treated with a proton pump inhibitor. Aliment Pharmacol Ther 17:954-964, 2003.
336 Gardner, J.D., Sloan, S., Miner, P.B. Jr., Robinson, M. Meal-stimulated gastric acid secretion and integrated gastric acidity in gastroesophageal reflux disease. Aliment Pharmacol Ther 17:945-953, 2003.
335 Gardner, J.D., Rodriguez-Stanley, S., Robinson, M., Miner, P.B. Jr. Cisapride inhibits meal-stimulated gastric acid secretion and postprandial gastric acidity in subjects with gastroesophageal reflux disease. Aliment Pharmacol Ther 16:1819-1829, 2002.
334 Gardner, J.D., Ciociola, A.A., Robinson, M, McIsaac, R.L. Determination of the time of onset of action of ranitidine and famotidine on gastric acidity. Aliment Pharmacol Ther 16:1-11, 2002.
333 Gardner, J.D., Ciociola, A.A., Robinson, M. Measurement of meal-stimulated gastric acid secretion by in vivo gastric autotitration. J. Appl. Physiol. 92: 427-434, 2002
332 Robinson, M., Rodriguez-Stanley, S., Ciociola, A.A., Filinto, J., Zubaidi, S, Miner, P.B. Jr., Gardner, J.D. Control of nocturnal gastric acidity: a role for low dose bedtime ranitidine to supplement daily omeprazole. Dig. Dis. Sci. 47: 265-273, 2002.
331 Gardner, J.D., Perdomo, C., Sloan, S., Hahne, W.F., Barth, J.A., Rodriguez-Stanley, S., and Robinson, M. Integrated acidity and rabeprazole pharmacology. Aliment. Pharmacol. Ther. 16: 455-464,2002.
330 Gardner, J.D., Rodriguez-Stanley, S., and Robinson, M. Integrated acidity and the pathophysiology of GERD. Am. J. Gastroenterol. 96: 1363-1370, 2001.
329 Robinson, M., Rodriguez-Stanley, S., Ciociola, A.A., Filinto, J., Zubaidi, S, Miner, P..B. Jr., Gardner, J.D. Synergy between low dose ranitidine and antacid in reducing gastric and esophageal acidity and relieving meal-induced heartburn. Aliment. Pharmacol. Ther. 15: 1365-1374, 2001.
328 Joshi, S. N. and Gardner, J.D. Gastrin and colon cancer: A unifying hypothesis. Dig, Dis. 14: 334-344, 1996.
327 Bastani, B., Yang, L., Baldassare, J.J., Pollo, D.A. and Gardner, J.D. Cellular distributions of isoforms of protein kinase C (PKC) in pancreatic acini. Biochim. Biophys. Acta. 1269: 307-315, 1995.
326 Huang, S-C., Talkad, V.D., Fortune, K.P., Jonnalagadda, S., Severi, C., Delle Fave, G. and Gardner, J.D. Modulation of cholecystokinin activity by albumin. Proc. Natl. Acad. Sci. USA. 92: 10312-10316, 1995.
325 Huang, S-C., Fortune, K.P., Wank, S.A., Kopin, A.S. and Gardner, J.D. Multiple affinity states of different cholecystokinin (CCK) receptors. J. Biol. Chem. 269: 26121-26126, 1994
324 Pollo, D.A., Baldassare, J.J., Honda, T., Henderson, P.A., Talkad, V.D. and Gardner, J.D. Effects of cholecystokinin (CCK) and other secretagogues on isoforms of protein kinase C (PKC) in pancreatic acini. Biochim. Biophys. Acta. 1224: 127-138, 1994.
323 Pandya, P.K., Huang, S-C., Talkad, V.D., Wank, S.A. and Gardner, J.D. Biochemical regulation of the three different states of the cholecystokinin (CCK) receptor in pancreatic acini. Biochim. Biophys. Acta. 1224: 117-126, 1994
322 Talkad, V.D., Patto, R.J., Metz, D.C., Turner, R.J., Fortune, K.P., Bhat, S.T. and Gardner, J.D. Characterization of the three different states of the cholecystokinin (CCK) receptor in pancreatic acini. Biochim. Biophys. Acta. 1224: 103-116, 1994.
321 Talkad, V.D., Fortune, K.P., Pollo, D.A., Shah, G.N., Wank, S.A. and Gardner, J.D. Direct demonstration of three different states of the pancreatic cholecystokinin receptor. Proc. Natl. Acad. Sci. USA. 91: 1868-1872, 1994.
320 Metz, D.C., Pradhan, T.K., Mrozinski, J.E., Jr., Jensen, R.T., Turner, R.J., Patto, R.J. and Gardner, J.D. Effect of inhibition of microsomal Ca2+-ATPase on cytoplasmic calcium and enzyme secretion in pancreatic acini. Biochim. Biophys. Acta. 1220: 199-208, 1994.
319 Bhat, S.T., Talkad, V., Pollo, D.A. and Gardner, J.D. Characterization of a persistent inhibitory action of L-364,718 on cholecystokinin-stimulated enzyme secretion in pancreatic acini. Pancreas. 9: 101-108, 1994.
318 Silen, M.L. and Gardner, J.D. Gastrointestinal peptides and cancer. Trends Endocrinol. Metab. 4: 131-135, 1993.
317 Bhat, S.T., Vinayek, R., Jensen, R.T. and Gardner, J.D. A newly recognized action of cholecystokinin on pancreatic acini-release of lactate dehydrogenase. Biochim. Biophys. Acta. 1177: 208-214, 1993.
316 Vinayek, R., Patto, R.J., Menozzi, D., Gregory, J., Mrozinski, J.E., Jensen, R.T. and Gardner, J.D. Occupation of low affinity cholecystokinin (CCK) receptors by CCK activates signal transduction and stimulates amylase secretion in pancreatic acinar cells. Biochim. Biophys. Acta. 1176: 183-191, 1993.
315 Presti, M.E. and Gardner, J.D. Receptor antagonists for gastrointestinal peptides. Am. J. Physiol. 264: G399-G406, 1993.
314 Metz, D.C., Pisegna, J.R., Ringham, G.L., Fishbeyn, V.A., Benya, R.V., Gardner, J.D. and Jensen, R.T. Prospective study of efficacy and safety of lansoprazole in Zollinger-Ellison Syndrome (ZES). Dig. Dis. Sci. 38: 245-256, 1993.
313 Jensen, R.T. and Gardner., J.D. Gastrinoma. In: The Exocrine Pancreas: Biology, Pathobiology and Diseases: 2nd Ed., Chapter 49. (V.L.W. Go, F.P. Brooks, E.P. DiMagno, J.D. Gardner, E. Lebenthal and G.A.Scheele, eds.). Raven Press Publishing Co., New York, N.Y., 1993, pp. 931-978.
312 Gardner, J.D. and Jensen., R.T. Receptors for secretagogues on pancreatic acinar cells. In: The Exocrine Pancreas: Biology, Pathobiology and Diseases: 2nd Ed., Chapter 9. (V.L.W. Go, F.P. Brooks, E.P. DiMagno, J.D. Gardner, E. Lebenthal and G.S. Scheele, eds.). Raven Press Publishing Co., New York, N.Y., 1993, pp. 151-166.
311 Yuan, D.S., Wank, S.A. and Gardner, J.D. Cibacron blue-induced enhancement of agonist binding to cholecystokinin (CCK) receptors in solubilized pancreatic membranes. Biochim. Biophys. Acta. 1146: 52-58, 1993.
310 Slimak, G.G., Stark, H.A., Egan, J.J., Jensen, R.T. and Gardner, J.D. Effect of verapamil on the cyclic AMP-mediated pathway for amylase secretion in rat pancreatic acini. Pancreas 8: 212-219, 1993.
309 Helander, H.F., Rutgersson, K., Helander, K.G., Gardner, J.D., Jensen, R.T. and Maton, P.N. Stereologic investigations of human gastric mucosa: II. Oxyntic mucosa from patients with Zollinger-Ellison syndrome. Scand. J. Gastroenterology 27: 875-883, 1992.
308 Metz, D.C., Patto, R.J., Mrozinski, J.E. Jr., Jensen, R.T., Turner, R.J. and Gardner, J.D. Thapsigargin defines the roles of cellular calcium in secretagogue-stimulated enzyme secretion from pancreatic acini. J. Biol. Chem. 267: 20620-20629, 1992.
307 Patto, R.J., Vinayek, R., Jensen, R.T. and Gardner, J.D. Carbachol does not down-regulate substance P receptors in pancreatic acini. Pancreas 7: 447-452, 1992.
306 Pisegna, J.R., Norton, J.A., Slimak, G.G., Metz, D.C., Maton, P.N., Gardner, J.D. and Jensen, R.T. Effects of curative gastrinoma resection on gastric secretory function and antisecretory drug requirement in the Zollinger-Ellison syndrome. Gastroenterology 102: 776-778, 1992.
305 Jensen, R.T. and Gardner, J.D. Zollinger-Ellison syndrome: Clinical presentation, pathology, diagnosis and treatment. In: Peptic ulcer and other acid-related diseases. (A. Dannenberg, D. Zakim, eds.). Academic Research Associates, Armonk, NY, 1991, pp.117-212.
304 Rusconi, L. De Castiglione, R., Gozzini, L., Ciomei, M., Molinari, I., Basilico, L., Rubino, T., Vinayek, R. and Gardner, J.D. Bombesin Receptor Antagonists. Analogues based on substance P antagonists. Il Farmaco 46: 725-742, 1991.
303 Vinayek, R., Amantea, M.A., Maton, P.N., Frucht, H., Gardner, J.D. and Jensen, R.T. Pharmacokinetics of oral and intravenous omeprazole in patients with Zollinger-Ellison syndrome. Gastroenterology 101: 138-147, 1991.
302 Menozzi, D., Vinayek, R., Jensen, R.T. and Gardner, J.D. Down-regulation and recycling of high affinity cholecystokinin receptors on pancreatic acinar cells. J. Biol. Chem. 266: 10385-10391, 1991.
301 Jensen, R.T. and Gardner, J.D. Cholecystokinin receptor antagonists in vitro. In: Cholecystokinin antagonists in gastroenterology: basic and clinical status. (C. Beglinger, G. Adler, eds). Springer-Verlag GmbH and Co., Heidelberg, West Germany, 1991, pp.93-111.
300 London, J.F., Shawker, T.H., Doppman, J.L., Miller, D.L., Frucht, H., Vinayek, R., Stark, H.A., Miller, L.S., Norton, J. A., Jensen, R.T., Gardner, J.D. and Maton, P.N. Prospective assessment of abdominal ultrasound in patients with Zollinger-Ellison syndrome. Radiology 178: 763-767, 1991.
299 Waxman, I., Gardner, J.D., Jensen, R.T. and Maton, P.N. Peptic ulcer perforation as the presentation of Zollinger-Ellison syndrome. Dig. Dis. Sci. 36: 19-24, 1991.
298 Miller, L., Gardner, J.D. Doppman, J.L. and Jensen, R.T. Zollinger-Ellison syndrome. In: Handbook of Experimental Pharmacology. (M.J. Collen, S.B. Benjamin, eds.). Springer-Verlag GmbH and Co., Heidelberg, West Germany, 1991, pp.349-400.
297 Huang, S-C., Yu, D-H., Wank, S.A., Gardner, J.D., Jensen, R.T. Characterization of the bombesin receptor on mouse pancreatic acini by chemical cross-linking. Peptides 11: 1143-1150, 1990.
296 Frucht, H., Norton, J.A., London, J.F., Vinayek, R., Doppman, J.L., Gardner, J.D., Jensen, R.T. and Maton, P.N. Detection of duodenal gastrinomas by operative endoscopic transillumination: a prospective study. Gastroenterology 99: 1622-1627, 1990.
295 Chiang, H-C.V., O'Dorisio, T.M., Huang, S-C., Maton, P.N., Gardner, J.D. and Jensen, R.T. Multiple hormone elevations in Zollinger-Ellison syndrome: prospective study of clinical significance and of the development of a second symptomatic pancreatic endocrine tumor syndrome. Gastroenterology 99: 1565-1575, 1990.
294 Maton, P.N., Lack, E.E., Colleen, M.J., Cornelius, M.J., David, E., Gardner, J.D. and Jensen, R.T. The effect of Zollinger-Ellison syndrome and omeprazole therapy on gastric oxyntic endocrine cells. Gastroenterology 99: 943-950, 1990.
293 Rowley, W.H., Sato, S., Huang, S-C., Collado-Escobar, D.M., Beaven, M.A., Wang, L-H., Martinez, J., Gardner, J.D. and Jensen, R.T. Cholecystokinin-induced formation of inositol phosphates in pancreatic acini. Am. J. Physiol. 259: G655-G665, 1990.
292 Vinayek, R., Murakami, M., Sharp, C.M., Jensen, R.T. and Gardner, J.D. Carbachol desensitizes pancreatic enzyme secretion by down-regulation of receptors. Am. J. Physiol. 258: G107-121, 1990.
291 Vinayek, R., Murakami, M., Sharp, C., Jensen, R.T. and Gardner, J.D. Carbachol-induced down-regulation of receptors for pancreatic secretagogues. Digestion 46: 112-124, 1990.
290 Maton, P.N., Pradhan, T., Zhou, Z-C., Gardner, J.D. and Jensen, R.T. Activities of calcitonin gene-related peptide (CGRP) and related peptides at the CGRP receptor. Peptides 11: 485-489, 1990.
289 Menozzi, D., Jensen, R.T. and Gardner, J.D. Dispersed pancreatic acinar cells and pancreatic acini. In: Methods in Enzymology, 192. (S. Fleischer and B. Fleischer, eds.). Academic Press, Inc., New York, NY, 1990, pp.271-279.
288 Wank, S.A., Jensen, R.T. and Gardner, J.D. Stimulation of secretion by secretagogues. In: Methods in Enzymology, 192. (S. Fleischer and B. Fleischer, eds.). Academic Press, Inc., New York, NY, 1990, pp.247-255
287 Vinayek, R. and Gardner, J.D. Receptor identification. In: Methods in Enzymology, 191. (S. Fleischer and B. Fleischer, eds.). Academic Press, Inc., New York, NY, 1990, pp.609-639.
286 Sutliff, V.E., Cherner, J.A., Jensen, R.T. and Gardner, J.D. Binding of 125I-CCK-8 and 125I-gastrin-I to dispersed chief cells from guinea pig stomach. Biochim. Biophys. Acta. 1052: 9-16, 1990.
285 Miller, L.S., Vinayek, R., Frucht, H., Gardner, J.D., Jensen, R.T. and Maton, P.N. Reflux esophagitis in patients with Zollinger-Ellison syndrome. Gastroenterology 98: 341-346, 1990.
284 Yu, D-H., Wank, S.A., Mantey, S., Gardner, J.D. and Jensen, R.T. Pancreatic receptors for cholecystokinin: evidence for three receptor classes. Am. J. Physiol. 258: G86-G95, 1990.
283 Cox, K.L., von Schrenck, T., Moran, T.H., Gardner, J.D. and Jensen, R.T. Characterization of cholecystokinin receptors in the sphincter of Oddi. Am. J. Physiol. 257: G873-G881, 1990.
282 Wank, S.A., Jensen, R.T. and Gardner, J.D. Pancreatic secretion at the cellular level. In: Current Topics in Gastroenterology and Hepatology. (G.N.J. Tytgat and M. van Blankenstein, eds.). Georg Thieme Verlag, Thieme Medical Publishers Inc., Stuttgart, New York, 1990, pp.428-436.
281 Jensen, R.T., Huang, S.C., von Schrenck, T., Wank, S.A. and Gardner, J.D. Cholecystokinin (CCK) receptor antagonists: ability to distinguish various classes of CCK receptors. In: GI Endocrinology: Receptors and post-receptor mechanisms. (J.C. Thompson, ed.). Academic Press, Inc., New York, NY, 1990, pp.95-113.
280 Vinayek, R., Frucht, H., London, J.F., Miller, L.S., Stark, H.A., Norton, J.A., Cederberg, C., Jensen, R.T., Gardner, J.D. and Maton, P.N. The use of intravenous omeprazole in patients with Zollinger-Ellison syndrome undergoing surgery. Gastroenterology 99: 10-16, 1990.
279 Doppman, J.L. Miller, D.L., Chang, R., Maton, P.N., London, J.F., Frucht, H., Gardner, J.D., Jensen, R.T. and Norton J.A. Gastrinomas: Localization by means of selective intraarterial injection of secretin. Radiology 174: 25-29, 1990.
278 Gardner, J.D. and Jensen, R.T. Role of receptors in expression of gastrointestinal hormone function. In: GI Endocrinology: Receptors and post-receptor mechanisms. (J.C. Thompson, ed.). Academic Press, Inc., New York, NY, 1990, pp.1-12.
277 Vinayek, R., Frucht, H., Chiang, H-C.V., Maton, P.N., Gardner, J.D. and Jensen, R.T. Zollinger-Ellison syndrome: recent advances in the management of the gastrinoma. In: Gastroenterology Clinics of North America, 19. (R.T. Jensen, ed.). W.B. Saunders Co., Philadelphia, PA, 1990, pp.197-217.
276 Jensen, R.T., Wank, S.A., Rowley, W.H., Sato, S. and Gardner, J.D. Interactions of CCK with pancreatic acinar cells. Trends Pharmacol. Sci. 10: 418-423, 1989.
275 Coy, D.H., Taylor, J.E., Jiang, N-Y., Kim, S.H., Wang, L-H., Chiang, S.C., Moreau, J-P., Gardner, J.D. and Jensen, R.T. Short-chain pseudopeptide bombesin receptor antagonists with enhanced binding affinities for pancreatic acinar and Swiss 3T3 cells display strong antimitotic activity. J. Biol. Chem. 264: 14691-14697, 1989.
274 Frucht, H., Howard, J.M., McCarthy, D.M., Maton, P.N., Stark, H.A., Gardner, J.D. and Jensen, R.T. Prospective study of the standard meal provocative test in Zollinger-Ellison syndrome. Am. J. Med. 87: 528-536, 1989.
273 London, J.F., Doppman, J.D., Maton, P.N., Gardner, J.D. and Jensen, R.T. Zollinger-Ellison syndrome in the intensive care setting. J. Intensive Care Med. 4: 272-283, 1989.
272 Sheppard, B.C., Norton, J.A., Doppman, J.L., Maton, P.N., Gardner, J.D. and Jensen, R.T. Management of islet cell tumors in patients with multiple endocrine neoplasia (MEN): a prospective study. Surgery 106: 1108-1117, 1989.
271 Maton, P.N., Gardner, J.D. and Jensen, R.T. Recent advances in management of gastric acid hypersecretion in patients with Zollinger-Ellison syndrome. In: Gastroenterology Clinics of North America. (R.T. Jensen, ed.). W.B. Saunders Co., Philadelphia, PA, 1989, 18: 847-863.
270 Jensen, R.T., von Schrenck, T., Yu, D-H., Wank, S.A. and Gardner, J.D. Pancreatic cholecystokinin (CCK) receptors: comparison with other classes of CCK receptors. In: The Neuropeptide Cholecystokinin (CCK). (Hughes, Dockray and Woodruff, eds.). Ellis Horwood, Ltd., West Sussex, England, 1989, pp.150-162
269 Maton, P.N., Vinayek, R., Frucht, H., McArthur, K.A., Miller, L.S., Saeed, Z.A., Gardner, J.D. and Jensen, R.T. Long-term efficacy and safety of omeprazole in patients with Zollinger-Ellison syndrome: a prospective study. Gastroenterology 97: 827-836, 1989.
268 Qian, J-M., Coy, C.H., Jiang, N.Y., Gardner, J.D. and Jensen, R.T. Reduced peptide bond pseudopeptide analogues of substance P. J. Biol. Chem. 264: 16667-16671, 1989.
267 Maton, P.N., Lack, E., Vinayek, R., Collen, M.J., Frucht, H., Miller, L.S., Gardner, J.D. and Jensen, R.T. Prospective assessment of the safety and efficacy of long-term omeprazole therapy in patients with Zollinger-Ellison syndrome. Scand. J. Gastroenterol 24: 181, 1989.
266 Frucht, H., Howard, J.M., Slaff, J.I., McCarthy, D.M., Maton, P.N., Wank, S.A., Vinayek, R., Gardner, J.D. and Jensen, R.T. Secretin and calcium provocative tests in Zollinger-Ellison syndrome. Ann. Int. Med. 111: 713-722, 1989.
265 Saeed, Z.A., Huang, S.C., Coy, D.H., Jiang, N.Y., Heinz-Erian, P., Mantey, S., Gardner, J.D. and Jensen, R.T. Effect of substitutions in position 12 of bombesin on antagonist activity. Peptides 10: 597-603, 1989.
264 Menozzi, D., Stark, H.A., Martinez, J., Jensen, R.T. and Gardner, J.D. Cholecystokinin (CCK)-induced desensitization of pancreatic enzyme secretion is mediated by low-affinity CCK receptors. Peptides 10: 337-341, 1989.
263 Maton, P.N., Norton, J.A., Nieman, L., Doppman, J.L., Gardner, J.D. and Jensen, R.T. Multiple endocrine neoplasia Type-2 with Zollinger-Ellison syndrome caused by solitary pancreatic gastrinoma. JAMA 262: 535-537, 1989.
262 Murakami, M., Vinayek, R., Jensen, R.T. and Gardner, J.D. Carbachol-induced down-regulation of high affinity receptors for vasoactive intestinal peptide. Am. J. Physiol. 257: G402-G408, 1989
261 Sutliff, V.E., Rattan, S., Gardner, J.D. and Jensen, R.T. Characterization of cholinergic receptors mediating pepsinogen secretion from chief cells. Am. J. Physiol. 257: G226-G234, 1989.
260 Huang, S.C., Zhang, L., Chiang, H-C.V., Wank, S.A., Maton, P.N., Gardner, J.D. and Jensen, R.T. Benzodiazepine analogues L365,260 and L364,718 as gastrin and pancreatic CCK receptor antagonists. Am. J. Physiol. 257: G169-G174, 1989.
259 Menozzi, D., Gardner, J.D., Jensen, R.T. and Maton. P.N. Properties of receptors for gastrin and cholecystokinin on gastric smooth muscle cells. Am. J. Physiol. 257: G73-G79, 1989.
258 Huang, S-C., Yu, D-H., Wank, S.A., Mantey, S., Gardner, J.D, and Jensen, R.T. Importance of sulfation of gastrin or cholecystokinin (CCK) on affinity for gastrin and CCK receptors. Peptides 10: 785-789, 1989.
257 Maton, P.N., Mackem, S.H., Norton, J.A., Gardner, J.D., O'Dorisio, T.M. and Jensen, R.T. Ovarian carcinoma as a cause of Zollinger-Ellison syndrome: Natural history, secretory products and response to provocative tests. Gastroenterology 97: 468-471, 1989.
256 Gardner, J.D. and Jensen, R.T. Pancreatic acini as second messenger models in exocrine secretion. In: Methods in Enzymology, Biomembranes and Biological Transport. (S. Fleischer and B. Fleischer, eds.). Academic Press, Inc., New York, NY, 1989, pp.590-594.
255 Gardner, J.D. and Jensen, R.T. Receptors for gut peptides and other secretagogues on pancreatic acinar cells. In: Handbook of Physiology. Am. J. Physiol. 1989, pp.171-192.
254 Coy, D.H., Heinz-Erian, P., Jiang, N-Y., Taylor, J., Moreau, J-P., Gardner, J.D. and Jensen, R.T. Progress in the development of competitive bombesin antagonists. Ann. N.Y. Acad. Sci. 547: 150-157, 1989.
253 Sato, S., Stark, H.A., Martinez, J., Beaven, M.A., Jensen, R.T. and Gardner, J.D. Receptor occupation, calcium mobilization and amylase release in pancreatic acini: effect of CCK-JMV-180. Am. J. Physiol. 257: G202-G209, 1989.
252 Maton, P.N., Gardner, J.D. and Jensen, R.T. Diagnosis and management of Zollinger-Ellison syndrome. In: Endocrinology and Metabolism Clinics of North America, 18. Plenum Publishing Corp., New York, NY, 1989, pp.519-543.
251 Saeed, Z.A., Norton, J.A., Frank, W.O., Young, M.D., Gardner, J.D. and Jensen, R.T. Parenteral antisecretory drug therapy in patients with Zollinger-Ellison syndrome. Gastroenterology 96: 1393-1402, 1989.
250 Maton, P.N., Gardner, J.D. and Jensen, R.T. Use of long-acting somatostatin analog SMS201-995 in patients with pancreatic islet cell tumors. Dig. Dis. Sci. 34: 28S-39S, 1989.
249 von Schrenck, T., Heinz-Erian, P., Moran, T., Mantey, S.A., Gardner, J.D. and Jensen, R.T. Neuromedin B receptor in esophagus: evidence for subtypes of bombesin receptors. Am. J. Physiol. 256: G747-G758, 1989.
248 Menozzi, D., Sato, S., Jensen, R.T. and Gardner, J.D. Cyclic GMP does not inhibit protein kinase C-mediated enzyme secretion in rat pancreatic acini. J. Biol. Chem. 264: 995-999, 1989.
247 Stark, H.A., Sharp, C.M., Sutliff, V.E., Martinez, J., Jensen, R.T. and Gardner, J.D. CCK-JMV-180: A peptide that distinguishes high-affinity cholecystokinin receptors from low-affinity cholecystokinin receptors. Biochim. Biophys. Acta. 1010: 145-150, 1989.
246 Younes, M., Wank, S.A., Vinayek, R., Jensen, R.T. and Gardner, J.D. Regulation of bombesin receptors on pancreatic acini by cholecystokinin. Am. J. Physiol. 256: G291-G298, 1989.
245 Zhou, Z-C., Gardner, J.D. and Jensen, R.T. Interaction of peptides related to VIP and secretin with guinea pig pancreatic acini. Am. J. Physiol. 256: G283-G290, 1989.
244 Gardner, J.D. and Jensen, R.T. Receptors for gut hormones. Ital. J. Gastroenterol. 20: 281-286, 1988
243 Jensen, R.T., Coy, D.H., Saeed, Z.A., Heinz-Erian, P., Mantey, S. and Gardner, J.D. Interaction of bombesin and related peptides with receptors on pancreatic acinar cells. Ann. N.Y. Acad. Sci. 547: 138-149, 1988.
242 Fraker, D., Norton, J.A., Saeed, Z.A., Maton, P.N., Gardner, J.D. and Jensen, R.T. A prospective study of perioperative and postoperative control of acid hypersecretion in patients with Zollinger-Ellison syndrome undergoing gastrinoma resection. Surgery 104: 1054-1063, 1988.
241 Zhang, L., Mantey, S., Jensen, R.T. and Gardner, J.D. An analogue of substance P with broad receptor antagonist activity. Biochim. Biophys. Acta. 972: 37-44, 1988.
240 Jensen, R.T., Yu, D-H. and Gardner, J.D. Interaction of cholecystokinin antagonists with receptors on pancreatic acini. In: Cholecystokinin Antagonists. (R.Y. Wang, ed.). Alan R. Liss, Inc., New York, NY, 1988, pp.53-72.
239 von Schrenck, T., Moran, T.H., Heinz-Erian, P., Gardner, J.D. and Jensen, R.T. Cholecystokinin receptors on gallbladder muscle and pancreatic acinar cells: a comparative study. Am. J. Physiol. 255: G512-G521, 1988.
238 Saeed, Z., Doppman, J.L., Norton, J.A., Maton, P.N., Gardner, J.D. and Jensen, R.T. Gastrinoma localization in Zollinger-Ellison syndrome. Int. Med. Spec. 9: 79-99, 1988.
237 Cherner, J.A., Jensen, R.T., Dubois, A., O'Dorisio, T.M., Gardner, J.D. and Metcalfe, D.D. Gastrointestinal dysfunction in systemic mastocytosis: a prospective study. Gastroenterology 95: 657-667, 1988.
236 von Schrenck, T., Howard, J.M., Doppman, J.L., Norton, J.A., Smith, F., Maton, P.N., Vinayek, R., Frucht, H., Wank, S.A., Gardner, J.D. and Jensen, R.T. Prospective study of chemotherapy in patients with metastatic gastrinoma. Gastroenterology 94: 1326-1334, 1988.
235 Gardner, J.D. and Jensen, R.T. Cell membrane receptors for secretagogues on pancreatic acinar cells. In: Advances in Metabolic Disorders, 2 (R. Levine and R. Luft, eds.). Academic Press, New York, NY, 1988, pp.113-140.
234 von Schrenck, T., Jensen, R.T. and Gardner, J.D. Characteristics of the pancreatic acinar cell receptors with which cholecystokinin interacts to increase cyclic AMP. In: Gastrin and Cholecystokinin: Chemistry, Physiology and Pharmacology. (J-P. Bali and J-P. Martinez, eds.). Elsevier Science Publishing, Amsterdam, New York, Oxford, 1988, pp.49-56.
233 Wank, S.A., Jensen, R.T. and Gardner, J.D. Kinetics of binding of cholecystokinin to pancreatic acini. Am. J. Physiol. 255: G106-G112, 1988.
232 Norton, J.A., Cromack, D.T., Shawker, T.H., Doppman, J.L., Comi, R., Gorden, P., Maton, P.N., Gardner, J.D. and Jensen, R.T. Intraoperative ultrasonographic localization of islet cell tumors: a prospective comparison to palpation. Ann. Surg. 207: 160-168, 1988
231 Jensen, R.T., Heinz-Erian, P., Mantey, S., Jones, S.W. and Gardner, J.D. Characterization of ability of various substance P antagonists to inhibit action of bombesin. Am. J. Physiol. 254: G883-G890, 1988.
230 Maton, P.N., Sutliff, V.E., Zhou, Z-C., Collins, S.M., Gardner, J.D. and Jensen, R.T. Characterization of receptors for calcitonin gene-related peptide on gastric smooth muscle cells. Am. J. Physiol. 254: G789-G794, 1988.
229 Coy, D.H., Heinz-Erian, P., Jiang, N-Y., Sasaki, Y., Tayler, J., Moreau, J-P., Wolfrey, W.T., Gardner, J.D. and Jensen, R.T. Probing peptide backbone function in bombesin: a reduced peptide bond analogue with potent and specific antagonist activity. J. Biol. Chem. 263: 5056-5060, 1988.
228 Cherner, J.A., Sutliff, V.E., Grybowski, D.A., Jensen, R.T. and Gardner, J.D. Functionally distinct receptors for cholecystokinin and gastrin on dispersed chief cells from guinea pig stomach. Am. J. Physiol. 254: G151-G155, 1988.
227 Maton, P.N., Frucht, H., Vinayek, R., Wank, S.A., Gardner, J.D. and Jensen, R.T. Medical management of patients with Zollinger-Ellison syndrome who have had previous gastric surgery: a prospective study. Gastroenterology 94: 294-299, 1988.
226 Norton, J.A., Doppman, J.L., Cornelius, M.J., Maton, P.N., Gardner, J.D. and Jensen, R.T. Effect of parathyroidectomy in patients with hyperparathyroidism and Zollinger-Ellison syndrome and multiple endocrine neoplasia Type I. Surgery 101: 958-966, 1987.
225 Yu, D-H., Noguchi, M., Zhou, Z-C., Villanueva, M.L., Gardner, J.D. and Jensen, R.T. Characterization of gastrin receptors on guinea pig pancreatic acini. Am. J. Physiol. 253: G793-G801, 1987.
224 Younes, M., Jensen, R.T. and Gardner, J.D. Cholecystokinin-induced residual stimulation of enzyme secretion from mouse pancreatic acini. Biochim. Biophys. Acta. 930: 410-418, 1987
223 Jensen, R.T. and Gardner, J.D. Gastrinoma. In: Current Therapy in Internal Medicine, 2. (T.M. Bayless, M.C. Brain and R.M. Cherniack, eds.). B.C. Decker, Inc., Philadelphia, PA, 1987, pp.626-629.
222 Zhou, Z-C., Gardner, J.D. and Jensen, R.T. Receptors for vasoactive intestinal peptide and secretin on guinea pig pancreatic acini. Peptides 8: 633-637, 1987.
221 McArthur, K.E., Raufman, J-P., Seaman, J.J., Ziemniak, J.A., Collen, M.J., Gardner, J.D. and Jensen, R.T. Cimetidine pharmacodynamics in patients with Zollinger-Ellison syndrome. Gastroenterology 93: 69-76, 1987.
220 Howard, J.M., Vinayek, R., Maton, P.N., Wank, S.A., Gardner, J.D. and Jensen, R.T. Famotidine: effective treatment of Zollinger-Ellison syndrome. J. Clin. Gastroenterol. 9:23-25, 1987.
219 McArthur, K.E., Wood, C.L., O'Dorisio, M.S., Zhou, Z-C., Gardner, J.D. and Jensen, R.T. Characterization of receptors for VIP on pancreatic acinar cell membranes using covalent cross-linking. Am. J. Physiol. 252: G404-G412, 1987.
218 Heinz-Erian, P., Coy, D.H., Tamura, M., Lance, V., Gardner, J.D. and Jensen, R.T. Bombesin analogues: a new class of bombesin receptor antagonists. Am. J. Physiol. 252: G439-G442, 1987.
217 Maton, P.N., Miller, D.L., Doppman, J.L., Collen, M.J., Norton, J.A., Vinayek, R., Slaff, J.I., Wank, S.A., Gardner, J.D. and Jensen, R.T. Role of selective angiography in the management of patients with Zollinger-Ellison syndrome. Gastroenterology 92: 913-918, 1987.
216 Wank, S.A., Doppman, J.L., Miller, D.L., Collen, M.J., Maton, P.N., Vinayek, R., Norton, J.A., Gardner, J.D. and Jensen, R.T. Prospective study of the ability of computerized axial tomography to localize gastrinomas in patients with Zollinger-Ellison syndrome. Gastroenterology 92: 905-912, 1987.
215 Vinayek, R., Jensen, R.T. and Gardner, J.D. Role of sulfate ester in influencing biologic activity of cholecystokinin-related peptides. Am. J. Physiol. 252: G178-G181, 1987.
214 Gardner, J.D. and Jensen, R.T. Secretagogue receptors on pancreatic acinar cells. In: Physiology of the Gastrointestinal Tract. 2nd edition (L.R. Johnson, J. Christensen, M.J. Jackson, E.D. Jacobsen and J.H. Walsh, eds.). Raven Press, New York, N.Y., 1987, pp.1109-1127.
213 Cherner, J.A., Doppman, J.L., Norton, J.A., Miller, D.L., Krudy, A.G., Harmon, J.W., Raufman, J-P., Collen, M.J., Maton, P.N., Gardner, J.D. and Jensen, R.T. Prospective assessment of selective venous sampling for gastrin to localize gastrinomas. Ann. Int. Med. 105: 841-847, 1986.
212 Vinayek, R., Howard, J.M., Maton. P.N., Wank, S.A., Slaff, J.I., Gardner, J.D. and Jensen, R.T. Famotidine in the therapy of gastric hypersecretory states. Am. J. Med. 81: 49-60, 1986.
211 Jensen, R.T., Zhou, Z-C., Murphy, R.P., Jones, S.W., Setnikar, I., Rovati, L.A. and Gardner, J.D. Structural features of various proglumide-related cholecystokinin receptor antagonists. Am. J. Physiol. 251: G839-G846, 1986.
210 Zhou, Z-C., Villanueva, M.L., Noguchi, M., Jones, S.W., Gardner, J.D. and Jensen, R.T. Mechanism of action of calcitonin gene-related peptide in stimulating pancreatic enzyme secretion. Am. J. Physiol. 251: G391-G397, 1986.
209 Maton, P.N., Gardner, J.D. and Jensen, R.T. The incidence and etiology of Cushing's syndrome in patients with Zollinger-Ellison syndrome. N. Engl. J. Med. 315: 1-5, 1986.
208 Howard, J.M., Chremos, A.N., Cornelius, M.J., Collen, M.J., Maton, P.N., Gardner, J.D. and Jensen, R.T. Famotidin beim Zollinger-Ellison-Syndrom. In: Famotidin - ein Fortschritt in der Therapie saurebedingter Erkrankungen. (B. Simon, G. Bianchi Porro and Hans-Gerd Dammann, eds.). Georg Thieme Verlag, Stuttgart-New York, 1986, pp.82-93.
207 Jensen, R.T., Maton, P.N. and Gardner, J.D. The current management of Zollinger-Ellison syndrome. Drugs 32: 188-196, 1986.
206 Norton, J.A., Doppman, J.L., Collen, M.J., Harmon, J.W., Maton, P.N., Gardner, J.D. and Jensen, R.T. Prospective study of gastrinoma localization and resection in patients with Zollinger-Ellison syndrome. Ann. Surg. 204: 468-479, 1986.
205 McArthur, K.E., Collen, M.J., Cherner, M.J., Howard, J.M., Maton, P.N., Jensen, R.T. and Gardner, J.D. Omeprazole: an effective drug for Zollinger-Ellison syndrome. Scand. J. Gastroenterol 21: 182-183, 1986.
204 Sutliff, V.E., Jensen, R.T. and Gardner, J.D. Actions of vasoactive intestinal peptide and secretin on chief cells prepared from guinea pig stomach. Am. J. Physiol. 251: G96-G102, 1986.
203 Maton, P.N., Jensen, R.T. and Gardner, J.D. Cholecystokinin receptor antagonists. Horm. Metab. Res. 1: 2-9, 1986.
202 Jensen, R.T. and Gardner, J.D. Structure-function studies of agonists and antagonists for gastrointestinal peptide receptors on pancreatic acinar cells. In: Neural and Endocrine Peptides and Receptors. (T.W. Moody, ed.). Plenum Publishing Co., New York, N.Y., 1986, pp.485-500.
201 Wank, S.A., Gardner, J.D. and Jensen, R.T. When to suspect a hypersecretory syndrome. Diagnosis 8: 62-74, 1986.
200 Norton, J.A., Sugarbaker, P.H., Doppman, J.L., Wesley, R.A., Maton, P.N., Gardner, J.D. and Jensen, R.T. Aggressive resection of metastatic disease in selected patients with malignant gastrinoma. Ann. Surg. 203: 352-359, 1986.
199 Gardner, J.D. and Jensen, R.T. Receptors and cell activation associated with pancreatic enzyme secretion. In: Annual Review of Physiology. (R.M. Berne, ed.). Annual Reviews, Inc., Palo Alto, Ca, 1986, pp.103-117.
198 Jensen, R.T., Doppman, J.L. and Gardner, J.D. Gastrinoma. In: The Exocrine Pancreas: Biology, Pathobiology and Diseases. (V.L.W. Go, F.P. Brooks, E.P. DiMagno, J.D. Gardner, E. Lebenthal and G.A. Scheele, eds.). Raven Press, New York, N.Y., 1986, pp.727-744.
197 Gardner, J.D. and Jensen, R.T. Receptors mediating the actions of secretagogues on pancreatic acinar cells. In: The Exocrine Pancreas: Biology, Pathobiology and Diseases, 1985-1986. (V.L.W. Go, F.P. Brooks, E.P. DiMagno, J.D. Gardner, E. Lebenthal, and G.A. Scheele, eds.). Raven Press, New York, N.Y., 1986, pp.109-122.
196 Maton, P.N., O'Dorisio, T.M., O'Dorisio, M.S., Malarkey, W.B., Gower, W.R., Gardner, J.D. and Jensen, R.T. Successful therapy of pancreatic cholera with the long-acting somatostatin analogue SMS201-995: relation between plasma concentrations of drug and clinical and biochemical responses. Scand. J. Gastroenterol 21: 181-186, 1986.
195 McArthur, K.E., Jensen, R.T. and Gardner, J.D. Treatment of acid-peptic diseases by inhibition of gastric H+,K+-ATPase. In: Annual Review of Medicine, 37. (W.P. Creger, ed.). Annual Reviews, Inc., Palo Alto, Ca., 1986, pp.97-105.
194 Jensen, R.T. and Gardner, J.D. Gastrinoma. In: Current Therapy in Gastroenterology and Liver Disease, 1985-1986. (T.M. Bayless, ed.). B.C. Decker, Inc., Philadelphia, Pa, 1986, pp.77-80.
193 Howard, J.M., Collen, M.J., McArthur, K.E., Cherner, J.A., Maton, P.N., Gardner, J.D. and Jensen, R.T. Comparison of famotidine with ranitidine and cimetidine in the treatment of Zollinger-Ellison syndrome. Digestion 32: 59-61, 1985.
192 Jensen, R.T., Murphy, R.B., Trampota, M., Schneider, L.H., Jones, S.W., Howard, J.M. and Gardner, J.D. Proglumide analogues: potent cholecystokinin receptor antagonists. Am. J. Physiol. 249: G214-G220, 1985.
191 Noguchi, M., Adachi, H., Gardner, J.D. and Jensen, R.T. Calcium-activated, phospholipid-dependent protein kinase in pancreatic acinar cells. Am. J. Physiol. 248: G692-G701, 1985.
190 Howard, J.M., Chremos, A.N., Collen, M.J., McArthur, K.E., Cherner, J.A., Maton, P.N., Ciarleglio, C.A., Cornelius, M.J., Gardner, J.D. and Jensen, R.T. Famotidine, a new, potent, long-acting histamine H2-receptor antagonist: Comparison with cimetidine and ranitidine in the treatment of Zollinger-Ellison syndrome. Gastroenterology 88: 1026-1033, 1985.
189 Maton, P.N., O'Dorisio, T.M., Howe, B.A., McArthur, K.E., Howard, J.M., Cherner, J.A., Malarkey, W.B., Collen, M.J., Gardner, J.D. and Jensen, R.T. Effect of a long-acting somatostatin analogue (SMS 201-995) in a patient with pancreatic cholera. N. Eng. J. Med. 312: 17-21, 1985.
188 Maton, P.N., Sutliff, V.E., Jensen, R.T. and Gardner, J.D. Carbobenzoxy-amino acids: requirements for cholecystokinin receptor antagonist activity. Am. J. Physiol. 248: G479-G484, 1985.
187 Howard, J.M., Jensen, R.T. and Gardner, J.D. Bombesin-induced residual stimulation of amylase release from mouse pancreatic acini. Am. J. Physiol. 248: G196-G199, 1985.
186 McArthur, K.E., Collen, M.J., Maton, P.N., Cherner, J.A., Howard, J.M., Ciarleglio, C.A., Cornelius, M.J., Jensen, R.T. and Gardner, J.D. Omeprazole: effective convenient therapy for Zollinger-Ellison syndrome. Gastroenterology 88: 939-944, 1985.
185 Gardner, J.D., Knight, M., Sutliff, V.E. and Jensen, R.T. N-terminal fragments of CCK-26-33 as cholecystokinin receptor antagonists in guinea pig pancreatic acini. Am. J. Physiol. 248: G98-G102, 1985.
184 Gardner, J.D. and Jensen, R.T. Preparation of dispersed pancreatic acinar cells and dispersed pancreatic acini. In: Methods in Enzymology. Peptide Hormone Action, 109. (L. Birnbaumer and B.W. O'Malley, eds.). Academic Press, New York, N.Y., 1985, pp.288-293.
183 Jensen, R.T. and Gardner, J.D. Assay for the cholecystokinin receptor on pancreatic acini. In: Methods in Enzymology. Peptide Hormone Action, 109. (L. Birnbaumer and B.W. O'Malley, eds.). Academic Press, New York, N.Y.. 1985, pp.64-69.
182 Krudy, A.G., Doppman, J.L., Jensen, R.T., Norton, J.A., Collen, M.J., Shawker, T.H., Gardner, J.D., McArthur, K.E. and Gorden, P. Localization of islet cell tumors by dynamic CT. Amer. J. Radiol. 143: 585-589, 1984.
181 Knight, M., Tamminga, C.A., Ito , Y., Gardner, J.D. and Chase, T.N. Purification of a cholecystokinin fragment peptide in the horizontal flow-through coil planet centrifuge. J. Chromatog. 301: 277-281, 1984.
180 Gardner, J.D. and Jensen, R.T. Characterization of receptors for gastrointestinal peptides. In: Physiology of the Gut. (J.M. Polak, S.R. Bloom, N.A. Wright and A.G. Butler, eds.). Glaxo Group Research Ltd., Ware, Herts, U.K., 1984, pp.7-18.
179 Jensen, R.T. and Gardner, J.D. Receptors for secretagogues on pancreatic acinar cells. J. Pediatr. Gastroenterol. Nutr. 3: S25-S35, 1984.
178 Collen, M.J., Gardner, J.D. and Jensen, R.T. The use of ranitidine in gastric hypersecretory states. In: Perspective on Therapeutics in Northern Europe - The Use of Ranitidine in Gastroenterology. Theracom, Ltd., London, 1984, pp.7-8.
177 Howard, J.M., Knight, M., Jensen, R.T. and Gardner, J.D. Discovery of an analogue of cholecystokinin with partial agonist activity. Am. J. Physiol. 247: G261-G264, 1984.
176 Jensen, R.T., Collen, M.J., McArthur, K.E., Howard, J.M., Maton, P.N., Cherner, J.A. and Gardner, J.D. Comparison of the effectiveness of ranitidine and cimetidine in inhibiting acid secretion in patients with gastric hypersecretory states. In: Ranitidine: Therapeutic Advances - 1984. (J.J. Misiewicz and J.R. Wood, eds.). Excerpta Medica, Amsterdam, 1984, pp. 113-143.
175 Adler, G., Kern, H.F., Pan, G-Z. and Gardner, J.D. Secretagogue-induced membrane alterations in dispersed acini from rat pancreas. Eur. J. Cell Biol. 33: 234-241, 1984.
174 Jensen, R.T., Jones, S.W., Folkers, K. and Gardner, J.D. A synthetic peptide that is a bombesin receptor antagonist. Nature 309: 61-63, 1984.
173 Raufman, J-P., Sutliff, V.E., Kasbekar, D.K., Jensen, R.T. and Gardner, J.D. Pepsinogen secretion from dispersed chief cells from guinea pig stomach. Am. J. Physiol. 247: G95-G104, 1984.
172 Bissonnette, B.M., Collen, M.J., Adachi, H., Jensen, R.T. and Gardner, J.D. Receptors for vasoactive intestinal peptide and secretin on rat pancreatic acini. Am. J. Physiol. 246: G710-G718, 1984.
171 Gardner, J.D. and Jensen, R.T. Cholecystokinin receptor antagonists. Am. J. Physiol. 246: G471-G476, 1984.
170 Jensen, R.T. and Gardner, J.D. The cellular basis of action of gastrointestinal peptides. In: Advances in Cyclic Nucleotide and Protein Phosphorylation Research. (P. Greengard, G.A. Robison, R. Paoletti, S. Nicosia, eds.). Raven Press, New York, N.Y., 1984, pp.375-383.
169 Jensen, R.T., Jones, S.W., Lu, Y-A., Xu, J-C., Folkers, K. and Gardner, J.D. Interaction of substance P antagonists with substance P receptors on dispersed pancreatic acini. Biochim. Biophys. Acta. 804: 181-191, 1984.
168 Collen, M.J., Howard, J.M., McArthur, K.E., Raufman, J-P., Cornelius, M.J., Ciarleglio, C.A., Gardner, J.D. and Jensen, R.T. Comparison of the effectiveness of ranitidine and cimetidine in inhibiting acid secretion in patients with gastric hypersecretory states. Ann. Int. Med. 100: 52-59, 1984.
167 Gardner, J.D., Knight, M., Sutliff, V.E. and Jensen, R.T. Derivatives of cholecystokinin-26-32 as cholecystokinin receptor antagonists in guinea pig pancreatic acini. Am. J. Physiol. 246: G292-G295, 1984.
166 Gardner, J.D. and Jensen, R.T. The significance of multiple secretagogue receptors on pancreatic acinar cells. In: Receptors and the Upper GI Tract. (B.I. Hirschowitz and J.D. Spenney, eds.). Advanced Therapeutics, Inc., New York, N.Y., 1983, pp.60-69.
165 Jensen, R.T., Jones, S.W. and Gardner, J.D. Structure-function studies of N-acyl derivatives of tryptophan that function as specific cholecystokinin receptor antagonists. Biochim. Biophys. Acta. 761: 269-277, 1983.
164 Martinez, J., Briet, C., Winternitz, F., Castro, B., Gardner, J.D. and Mutt, V. Synthesis and biological properties of cholecystokinin 27-32 amide. CCK-26-32 NH2: a new class of cholecystokinin receptor antagonist. In: Peptides Structure and Function. Proceedings of 8th American Peptide Symposium. (V.J. Hruby and D.H. Rich, eds.). Pierce Chemical Co., Rockford, Il, 1983, pp.673-676.
163 Jensen, R.T., Pandol, S.J., Collen, M.J., Raufman, J-P. and Gardner, J.D. Diagnosis and management of the Zollinger-Ellison syndrome. J. Clin. Gastroenterol. 5: 123-131, 1983.
162 Gardner, J.D. and Jensen, R.T. Characterization of receptors for gastrointestinal peptides. Scand. J. Gastroenterol. 18: 7-18, 1983
161 Pandol, S.J., Sutliff, V.E., Jones, S.W., Charlton, C.G., O'Donohue, T.L., Gardner, J.D. and Jensen, R.T. Action of natural glucagon on pancreatic acini: due to contamination by previously undescribed secretagogues. Am. J. Physiol. 245: G703-G710, 1983.
160 Gardner, J.D., Sutliff, V.E., Walker, M.D. and Jensen, R.T. Effects of inhibitors of cyclic nucleotide phosphodiesterase on actions of cholecystokinin, bombesin and carbachol on pancreatic acini. Am. J. Physiol. 245: G676-G680, 1983.
159 Raufman, J-P., Kasbekar, D.K., Jensen, R.T. and Gardner, J.D. Potentiation of pepsinogen secretion from dispersed glands from rat stomach. Am. J. Physiol. 245: G525-G530, 1983.
158 Jensen, R.T., Charlton, C.G., Adachi, H., Jones, S,W., O'Donohue, T.L. and Gardner, J.D. Use of 125I-secretin to identify and characterize high-affinity secretin receptors on pancreatic acinar cells. Am. J. Physiol. 245: G186-G195, 1983.
157 Spanarkel, M., Martinez, J., Jensen, R.T. and Gardner, J.D. Cholecystokinin-27-32-Amide: A member of a new class of cholecystokinin receptor antagonists. J. Biol. Chem. 258: 6746-6749, 1983.
156 Jensen, R.T., Jones, S.W. and Gardner, J.D. COOH-terminal fragments of cholecystokinin: A new class of cholecystokinin receptor antagonists. Biochim. Biophys. Acta. 757: 250-258, 1983
155 Gardner, J.D. and Jensen, R.T. Gastrointestinal Peptides: The Basis of Action at the Cellular Level. In: Recent Progress in Hormone Research. Academic Press, 1983, pp.211-243.
154 Gardner, J.D. Mechanism by which dibutyryl cyclic GMP antagonizes the action of cholecystokinin. Gastroenterology 84: 1619-1621, 1983.
153 McArthur, K.E., Jensen, R.T. and Gardner, J.D. The actions of tetraethylammonium on dispersed acini from guinea pig pancreas. Biochim. Biophys. Acta. 762: 373-377, 1983.
152 Jensen, R.T., Collen, M.J., Pandol, S.J., Allende, H.D., Raufman, J-P., Bissonnette, B.M., Duncan, W.C., Durgin, P.L., Gillin, J.C. and Gardner, J.D. Cimetidine-induced impotence and breast changes in patients with gastric hypersecretory states. N. Eng. J. Med. 308: 883-887, 1983.
151 Collins, S.M. and Gardner, J.D. Cholecystokinin-induced contraction of dispersed smooth muscle cells from guinea pig stomach: antagonism by proglumide and glucagon. Am. J. Physiol. 243: G497-G504, 1983.
150 Jensen, R.T., Gardner, J.D., Raufman, J-P., Pandol, S.J., Doppman, J.L. and Collen, M.J. Zollinger-Ellison Syndrome - Current Concepts and Management. Ann. Int. Med. 98: 59-75, 1983.
149 Raufman, J-P., Collins, S.M., Pandol, S.J., Korman, L.Y., Collen, M.J., Cornelius, M.J., Feld, M.K., McCarthy, D.M., Gardner, J.D. and Jensen, R.T. Reliability of symptoms in assessing control of gastric acid secretion in patients with Zollinger-Ellison syndrome. Gastroenterology 84: 108-113, 1983.
148 Kasbekar, D.K., Jensen, R.T. and Gardner, J.D. Pepsinogen secretion from dispersed glands from rabbit stomach. Am. J. Physiol. 244: G392-G396, 1983.
147 Pandol, S.J., Jensen, R.T. and Gardner, J.D. Mechanism of [Tyr4]bombesin-induced desensitization in dispersed acini from guinea pig pancreas. J. Biol. Chem. 257: 12024-12029, 1982.
146 Korman, L.Y., Lemp, G.F., Jackson, M.J. and Gardner, J.D. Mechanism of action of ATP on intestinal epithelial cells: cyclic AMP-mediated stimulation of active ion transport. Biochim. Biophys. Acta. 721: 47-54, 1982.
145 Martinez, J., Winternitz, F., Bodanszky, M., Gardner, J.D., Walker, M.D. and Mutt, V. Synthesis and some pharmacological properties of Z-Tyr(SO3H)-Met-Gly-Trp-Met-Asp(Phe-NH2)-OH, a 32-β-Aspartyl analogue of cholecystokinin (pancreozymin) 27-33. J. Med. Chem. 25: 589-593, 1982.
144 Villanueva, M.L., Martinez, J., Bodanszky, M., Collins, S.M., Jensen, R.T. and Gardner, J.D. Selective modification of the ability of cholecystokinin to cause residual stimulation of pancreatic enzyme secretion. Am. J. Physiol. 243: G214-G217, 1982.
143 Jensen, R.T., Lemp, G.F. and Gardner, J.D. Interactions of COOH-terminal fragments of cholecystokinin with receptors on dispersed acini from guinea pig pancreas. J. Biol. Chem. 257: 5554-5559, 1982.
142 Gardner, J.D., Korman, L.Y., Walker, M.D. and Sutliff, V.E. Effects of inhibitors of cyclic nucleotide phosphodiesterase on the actions of VIP and secretin on pancreatic acini. Am. J. Physiol. 242: G547-G551, 1982.
141 Pan, G.Z., Collen, M.J. and Gardner, J.D. Action of cholera toxin on dispersed acini from rat pancreas: post-receptor modulation involving cyclic AMP and calcium. Biochim. Biophys. Acta. 720: 338-345, 1982.
140 Gardner, J.D. and Jensen, R.T. Receptor modulation of calcium and cyclic AMP: differences in coupling to specific hormone-receptor complexes in cells responsive to several hormones. In: Horizons in Biochemistry and Biophysics. (L.D. Kohn, ed.). John Wiley and Sons, Ltd., New York, NY, 6, 1982, pp.277-397.
139 Raufman, J-P., Jensen, R.T., Pisano, J.J. and Gardner, J.D. Actions of Gila monster venom on dispersed acini from guinea pig pancreas. Am. J. Physiol. 242: G470-G474, 1982.
138 Barlas, N., Jensen, R.T. and Gardner, J.D. CCK-induced restricted stimulation of pancreatic enzyme secretion. Am. J. Physiol. 242: G464-G469, 1982.
137 Collen, M.J., Sutliff, V.E., Pan, G.Z. and Gardner, J.D. Post-receptor modulation of the action of VIP and secretin on pancreatic enzyme secretion by secretagogues that cause mobilization of cellular calcium. Am. J. Physiol. 242: G423-G428, 1982.
136 Villanueva, M.L., Collins, S.M., Jensen, R.T. and Gardner, J.D. Structural requirements for the action of cholecystokinin on enzyme secretion from pancreatic acini. Am. J. Physiol. 242: G416-G422, 1982.
135 Gardner, J.D. and Jensen, R.T. Receptor antagonists of the actions of gastrointestinal peptides on pancreatic acinar cells. In: Hormone Antagonists. (M.K. Agarwal, ed.). Walter de Gruyter and Co., Berlin-New York, 1982, pp.527-547.
134 Jensen, R.T., Lemp, G.F., Beinfeld, M.C. and Gardner, J.D. Actions of natural GIP on pancreatic acinar cells: Due to contamination with cholecystokinin. Gastroenterology 82: 20-25, 1982.
133 Barlas, N., Jensen, R.T., Beinfeld, M.C. and Gardner, J.D. Cyclic nucleotide antagonists of cholecystokinin: structural requirements for interaction with the cholecystokinin receptor. Am. J. Physiol. 242: G161-G167, 1982.
132 Martinez, J., Winternitz, F., Gardner, J.D. and Mutt, V. Synthesis of new active analogs of the C-terminal heptapeptide of CCK-27-33, role of the residue in position 32 in biological activities. In: Peptides, Proc. of the 7th American Peptide Symposium. (D.H. Rich and E. Gross, eds.). Pierce Chemical Co., Rockford, Il., 1981, pp.649-652.
131 Jensen, R.T., Tatemoto, K., Mutt, V., Lemp, G.F. and Gardner, J.D. Actions of a newly isolated intestinal peptide PHI on pancreatic acini. Am. J. Physiol. 241: G498-G502, 1981.
130 Gardner, J.D. and Jensen, R.T. Regulation of pancreatic exocrine secretion in vitro - the action of secretagogues. Phil. Trans. Royal Society. London. 296: 17-26, 1981.
129 Adachi, H., Rajh, H.M., Tesser, G.I., DePont, J.J.H.H.M., Jensen, R.T. and Gardner, J.D. Interaction of tryptophan-modified analogues of cholecystokinin-octapeptide with cholecystokinin receptors on pancreatic acini. Biochim. Biophys. Acta. 678: 358-363, 1981.
128 Pan, G.Z., Martinez, J., Bodanszky, M. Jensen, R.T. and Gardner, J.D. The importance of the amino acid in position 32 of cholecystokinin in determining its interaction with cholecystokinin receptors on pancreatic acini. Biochim. Biophys. Acta. 678: 352-357, 1981.
127 Hahne, W.F., Jensen, R.T., Lemp, G.F. and Gardner, J.D. Proglumide and benzotript: Members of a different class of cholecystokinin receptor antagonists. Proc. Natl. Acad. Sci. USA. 78: 6304-6308, 1981.
126 Moroder, L., Wilschowitz, L., Gemeiner, M., Gohring, W., Knof, S., Scharf, R., Thamm, P., Gardner, J.D., Solomon, T.E. and Wunsch, E. Zur Synthese von Cholecystokinin-Pankreozymin. Hoppe-Seyler's Z. Physiol. Chem. 362: 929-942, 1981.
125 Wunsch, E., Moroder, L., Wilschowitz, L., Gohring, W., Scharf, R. and Gardner, J.D. Zur Totalsynthese von Cholecystokinin-Pankreozymin. Hoppe-Seyler's Z. Physiol. Chem. 362: 143-152, 1981.
124 Abdelmoumene, S. and Gardner, J.D. Effect of extracellular manganese on amylase release from dispersed pancreatic acini. Am. J. Physiol. 241: G359-G364, 1981.
123 Collins, S.M., Abdelmoumene, S., Jensen, R.T. and Gardner, J.D. Reversal of cholecystokinin-induced persistent stimulation of pancreatic enzyme secretion by dibutyryl cyclic GMP. Am. J. Physiol. 240: G466-G471, 1981.
122 Collins, S.M., Abdelmoumene, S., Jensen, R.T. and Gardner, J.D. Cholecystokinin-induced persistent stimulation of enzyme secretion in pancreatic acini. Am. J. Physiol. 240: G459-G465, 1981.
121 Jensen, R.T., Collins, S.M., Pandol, S.J. and Gardner, J.D. Lessons from studies of secretagogue receptors on pancreatic acinar cells. In: Gut Hormones. (S.R. Bloom and J.M. Polak, eds.). Churchill Livingstone, Edinburgh, 1981, pp. 133-136.
120 Gardner, J.D. and Jensen, R.T. Regulation of pancreatic enzyme secretion in vitro. In: Physiology of the Gastrointestinal Tract. (L. Johnson, J. Christensen, M. Grossman, E.D. Jacobson and S.G. Schultz, eds.). Raven Press, New York, N.Y., 1981, pp.831-871.
119 Jensen, R.T. and Gardner, J.D. Identification and characterization of receptors for secretagogues on pancreatic acinar cells. Fed. Proc. 40: 2486-2496, 1981.
118 Bodanszky, M., Tolle, J.C., Gardner, J.D., Walker, M.D. and Mutt, V. Cholecystokinin (Pancreozymin): Synthesis and Properties of the Nα-Acetyl-derivative of Cholecystokinin 27-33. Int. J. Pept. Prot. Res. 16: 402-411, 1980.
117 Loveridge, N., Bitensky, L., Chayen, J., Hausamen, T.U., Fisher, J.M., Taylor, K.B., Gardner, J.D., Bottazzo, G.F. and Doniach, D. Inhibition of parietal cell function by human gammaglobulin containing gastric parietal cell antibodies. Clin. Exp. Immunol. 41: 264-270, 1980.
116 Gardner, J.D., Abdelmoumene, S., Lee, P.C., Collins, S.M. and Jensen, R.T. Secretagogue-induced desensitization in pancreatic acinar cells. In: Biology of Exocrine Pancreatic Cell. (A. Ribet, ed.). Elsevier/North-Holland, Amsterdam, 1980, pp.165-170.
115 Korman, L.Y., Walker, M.D. and Gardner, J.D. The action of theophylline on secretagogue-stimulated amylase release from dispersed pancreatic acini. Am. J. Physiol. 239: G324-G333, 1980.
114 Abdelmoumene, S. and Gardner, J.D. Cholecystokinin-induced desensitization in dispersed acini from guinea pig pancreas. Am. J. Physiol. 239: G272-G279, 1980.
113 Gardner, J.D., Walker, M.D., Martinez, J., Priestley, G.P., Natarajan, S. and Bodanszky, M. The importance of the amino acid in position 27 of cholecystokinin in determining its biological activity on pancreatic acinar cells. Biochim. Biophys. Acta. 630: 323-329, 1980.
112 Gardner, J.D., Rottman, A.J., Fink, M.L., Natarajan, S. and Bodanszky, M. Importance of the amino acid in position 15 of VIP and secretin in influencing their interactions with membrane receptors on pancreatic acinar cells. Endocrinologia Japonica, Supp. 1: 1-5, 1980.
111 Loveridge, N., Hoile, R.W., Johnson, A.G., Gardner, J.D. and Chayen, J. The cytochemical section-bioassay of gastrin-like activity. J. Immunoassay 1: 195-209, 1980.
110 Gardner, J.D. Pathogenesis of secretory diarrhea. In: Secretory Diarrhea, (M. Field, J.S. Fordtran and S. Schultz, eds.). Am. Physiol. Soc., Baltimore, Md., 1980, pp.153-158.
109 Pandol, S.J., Korman, L.Y., McCarthy, D.M. and Gardner, J.D. The beneficial effect of oral lithium carbonate in the treatment of pancreatic cholera syndrome. N. Eng. J. Med. 302: 1403-1405, 1980.
108 Gardner, J.D. and Jensen, R.T. Receptors mediating the actions of gastrointestinal peptides and other secretagogues on pancreatic acinar cells. In: Polypeptide Hormones. (R.F. Beers, Jr. and E.G. Bassett, eds.). Raven Press, New York, N.Y., 1980, pp.395-412.
107 Gardner, J.D., Walker, M.D. and Rottman, A.J. Effect of A23187 on amylase release from dispersed acini prepared from guinea pig pancreas. Am. J. Physiol. 238: G458-G466, 1980.
106 Jensen, R.T., Lemp, G.F. and Gardner, J.D. Interaction of cholecystokinin with specific membrane receptors on pancreatic acinar cells. Proc. Natl. Acad. Sci. USA. 77: 2079-2083, 1980.
105 Gardner, J.D. and Rottman, A.J. Evidence against cyclic GMP as a mediator of the actions of secretagogues on amylase release from guinea pig pancreas. Biochim. Biophys. Acta. 627: 230-243, 1980.
104 Lee, P.C., Jensen, R.T. and Gardner, J.D. Bombesin-induced desensitization of enzyme secretion in dispersed acini from guinea pig pancreas. Am. J. Physiol. 238: G213-G218, 1980.
103 Binder, H.J., Lemp, G.F. and Gardner, J.D. Receptors for vasoactive intestinal peptide and secretin on small intestinal epithelial cells. Am. J. Physiol. 238: G190-G196, 1980
102 Bodanszky, M., Martinez, J., Walker, M., Gardner, J.D. and Mutt, V. Cholecystokinin (pancreozymin) 5.1 Hormonally active desamino derivative of Tyr(SO3H)-Met-Gly-Trp-Met-Asp-Phe-NH2. J. Med. Chem. 23: 82-85, 1980.
101 Gardner, J.D. and Jensen, R.T. Receptors for secretagogues on pancreatic acinar cells. Am. J. Physiol. 238: G63-G66, 1980.
100 Jensen, R.T. and Gardner, J.D. Gastrointestinal peptides: receptors and mechanisms of action in pancreatic acinar cells. In: Peptides: Structure and Biological Function. Proceedings of 6th American Peptide Symposium. (E. Gross and J. Meienhofer, eds.). Pierce Chemical Co., Rockford, Il., 1979, pp.1001-1009.
99 Jensen, R.T. and Gardner, J.D. Interaction of physalaemin, substance P and eledoisin with specific membrane receptors on pancreatic acinar cells. Proc. Natl. Acad. Sci. USA. 76: 5679-5683, 1979.
98 Gardner, J.D. and Jensen, R.T. The physiologic and pharmacologic significance of potentiating interactions among secretagogues. In: Gut Peptides: Secretion, Function and Clinical Aspects. (A. Miyoshi, ed.). Kodansha LTD, Elsevier/North-Holland Biomedical Press, Tokyo, 1979, pp.154-156.
97 Gardner, J.D. and Jensen, R.T. Actions of pancreatic secretagogues in vitro: unresolved issues. In: Gut Peptides: Secretion, Function and Clinical Aspects. (A. Miyoshi, ed.). Kodansha, LTD, Elsevier/North-Holland Biomedical Press, Tokyo, 1979, pp.123-128.
96 Jensen, R.T. and Gardner, J.D. Receptors for secretagogues on pancreatic acinar cells: Different mechanisms of spareness. In: Hormone Receptors in Digestion and Nutrition, (S. Bonfils, P. Fromageot and G. Rosselin, eds.). Elsevier/North-Holland Biomedical Press, North Holland, 1979, pp.167-176.
95 Batzri, S. and Gardner, J.D. Action of histamine on cyclic AMP in guinea pig gastric cells: inhibitions by H1- and H2-receptor antagonists. J. Mol. Pharmacol. 16: 406-416, 1979.
94 Gardner, J.D. Hormones and diarrhea. In: Proceedings of the First International Colloquium in Gastroenterology, Frontiers of Knowledge in the Diarrheal Diseases. (H.D. Janowitz and D.B. Sachar, eds.). Projects in Health, Inc., Upper Montclair, NJ, 1979, pp.279-288.
93 Gardner, J.D. Biochemical basis of action of gastrointestinal hormones. World J. Surg. 3: 407-413, 1979.
92 Olinger, E.J. and Gardner, J.D. Action of VIP and secretin on adenylate cyclase activity in acinar cells from guinea pig pancreas. Gastroenterology 77: 704-713, 1979.
91 Gardner, J.D. and Rottman, A.J. Action of cholera toxin on dispersed acini from guinea pig pancreas. Biochim. Biophys. Acta. 585: 250-265, 1979.
90 Peikin, S.R., Costenbader, C.L. and Gardner, J.D. Actions of derivatives of cyclic nucleotides on dispersed acini from guinea pig pancreas: Discovery of a competitive antagonist of the action of cholecystokinin. J. Biol. Chem. 254: 5321-5327, 1979.
89 Uhlemann, E.R., Robberecht, P. and Gardner, J.D. Effects of alcohols on the actions of VIP and secretin on acinar cells from guinea pig pancreas. Gastroenterology 76: 917-925, 1979.
88 Gardner, J.D., Costenbader, C.L. and Uhlemann, E.R. Effect of extracellular calcium on amylase release from dispersed pancreatic acini. Am. J. Physiol. 236: E754-E762, 1979.
87 Uhlemann, E.R., Rottman, A.J. and Gardner, J.D. Actions of peptides isolated from amphibian skin on amylase release from dispersed pancreatic acini. Am. J. Physiol. 236: E571-E576, 1979.
86 Gardner, J.D., Rottman, A.J., Natarajan, S. and Bodanszky, M. Interaction of secretin5-27 and its analogues with hormone receptors on pancreatic acini. Biochim. Biophys. Acta. 583: 491-503, 1979.
85 Gardner, J.D. Regulation of pancreatic exocrine function in vitro: initial steps in the action of secretagogues. Ann. Rev. Physiol. 41: 55-66, 1979.
84 Gardner, J.D. Receptors for gastrointestinal hormones. Gastroenterology 76: 202-214, 1979.
83 Jensen, R.T., Moody, T., Pert, C., Rivier, J.E. and Gardner, J.D. Interaction of bombesin and litorin with specific membrane receptors on pancreatic acinar cells. Proc. Natl. Acad. Sci. USA. 75: 6139-6143, 1978.
82 Brown, E.M., Spiegel, A.M., Gardner, J.D. and Aurbach, G.D. Direct identification and characterization of β-adrenergic receptors and functional relationship of adenylyl cyclase. In: Receptors and Hormone Action III (L. Birnbaumer and B.W. O'Malley, eds.). Acad. Press, New York, 1978, pp. 101-131.
81 Peikin, S.R., and Rottman, A.J., Batzri, S. and Gardner, J.D. Kinetics of amylase release by dispersed acini prepared from guinea pig pancreas. Am. J. Physiol. 235: 743-750, 1978.
80 Bodanszky, M., Natarajan, S., Gardner, J.D., Makhlouf, G. and Said, S.I. Synthesis and some pharmacological properties of the 23-peptide 15-lysine-secretin 5-27: Special role of the residue in position 15 in biological activity of VIP. J. Med. Chem. 21: 1171-1173, 1978.
79 Bodanszky, M., Martinez, J., Priestley, G.P., Gardner, J.D. and Mutt, V. Cholecystokinin (pancreozymin). IV1Synthesis and properties of a biologically active analogue of the C-terminal 7-peptide with ε-hydroxynorleucine sulfate replacing tyrosine sulfate. J. Med. Chem. 21: 1030-1035, 1978.
78 Gardner, J.D. Receptors and gastrointestinal hormones. In: Gastrointestinal Disease, (M.H. Sleisenger and J.S. Fordtran, eds.). W.B. Saunders and Co. Philadelphia, PA, 1, 1978, pp. 179-195.
77 Jensen, R.T. and Gardner, J.D. Cyclic nucleotide-dependent protein kinase activity in acinar cells from guinea pig pancreas. Gastroenterology 75: 806-816, 1978.
76 Lopatin, R.N. and Gardner, J.D. Effects of calcium on the ability of various agents to increase cyclic GMP in pancreatic acinar cells. Biochim. Biophys. Acta. 543: 465-475, 1978.
75 May, R.J., Conlon, T.P., Erspamer, V. and Gardner, J.D. Actions of peptides isolated from amphibian skin on pancreatic acinar cells. Am. J. Physiol. 235: E112-E118, 1978.
74 Gardner, J.D. Diarrheal syndromes associated with neoplasms. In: Pathophysiology of Diarrhea. (S. Cohen, ed.). Searle Laboratories, San Juan, Puerto Rico, 1978, pp.1-4.
73 Batzri, S. and Gardner, J.D. Potassium transport in dispersed mucosal cells from guinea pig stomach. Biochim. Biophys. Acta. 508: 328-338, 1978.
72 Batzri, S. and Gardner, J.D. Cellular cyclic AMP in dispersed mucosal cells from guinea pig stomach. Biochim. Biophys. Acta. 541: 181-189, 1978.
71 Gardner, J.D., Jackson, M.J., Batzri, S. and Jensen, R.T. Potential mechanisms of interaction among secretagogues. Gastroenterology 74: 348-354, 1978.
70 Gardner, J.D. Plasma VIP in patients with watery diarrhea syndrome. Am. J. Dig. Dis. 23: 370-373, 1978.
69 Gardner, J.D. and McCarthy, D.M. Arguments against vasoactive intestinal peptide being the cause of the watery diarrhea syndrome. In: Gut Hormones. (S. Bloom, ed.). Churchill Livingstone, Edinburgh, London and New York, 1978, pp.570-573.
68 Gardner, J.D., Long, B.W., Uhlemann, E.R. and Peikin, S.R. Membrane receptors for VIP and secretin. In: Gut Hormones. (S. Bloom, ed.). Churchill Livingstone, Edinburgh, London and New York, 1978, pp.92-96.
67 Gardner, J.D. and Hahne, W.F. Calcium transport in dispersed acinar cells from rat pancreas. Biochim. Biophys. Acta. 471: 466-476, 1977.
66 McCarthy, D.M., Ollinger, E.J., May, R.J., Long, B.W. and Gardner, J.D. H2-histamine receptor blocking agents in the Zollinger-Ellison syndrome: Experience in 7 cases and implications for long term therapy. Ann. Int. Med. 87: 668-675, 1977.
65 Sjodin, L. and Gardner, J.D. Effect of cholecystokinin variant (CCK39) on dispersed acinar cells from guinea pig pancreas. Gastroenterology 73: 1015-1018, 1977.
64 Long, B.W. and Gardner, J.D. Effects of cholecystokinin on adenylate cyclase activity in dispersed pancreatic acinar cells. Gastroenterology 73: 1008-1014, 1977.
63 Waldman, D.B., Gardner, J.D., Zfass, A.M. and Makhlouf, G.M. Effects of vasoactive intestinal peptide (VIP), secretin and related peptides on colonic transport and adenylate cyclase activity. Gastroenterology 73: 518-523, 1977.
62 Bodanszky, M., Natarajan, S., Hahne, W. and Gardner, J.D. Cholecystokinin-pancreozymin. III. Synthesis and properties of an analog of the C-terminal heptapeptide with serine-sulfate replacing tyrosine-sulfate. J. Med. Chem. 20: 1047-1050, 1077.
61 Gardner, J.D., Conlon, T.P., Beyerman, H.C. and Van Zon, A. Interaction of synthetic 10-tyrosil analogues of secretin with hormone receptors on pancreatic acinar cells. Gastroenterology 73: 52-56, 1977.
60 Gardner, J.D. and Jackson, M.J. Regulation of amylase release from dispersed pancreatic acinar cells. J. Physiol. 270: 439-444, 1977.
59 Dubois, A., Natelson, B.H., Van Eerdewegh, P. and Gardner, J.D. Gastric emptying and secretion in the rhesus monkey. Am. J. Physiol. 232: E186-E192, 1977.
58 Gardner, J. D., Christophe, J.P., Conlon, T.P. and Frandsen, E.K. Initial steps in the actin of cholecystokinin and cholinergic agents on pancreatic acinar cells. In: Hormonal Receptors in Digestive Tract Physiology. (S. Bonfils, P. Fromageot and G. Rosselin, eds.). Elsevier/North Holland Biomedical Press, North Holland, 1977, pp.237-246.
57 Gardner, J.D., Christophe, J., Robberecht, P. and Conlon, T.P. Membrane receptors for VIP and secretin in pancreatic acinar cells. In: Hormonal Receptors in Digestive Tract Physiology. (S. Bonfils, P. Fromageot and G. Rosselin, eds.). Elsevier/North-Holland Biomedical Press, North Holland, 1977, pp.227-235.
56 Dubois, A., Van Eerdewegh, P. and Gardner, J.D. Gastric emptying and secretion in Zollinger-Ellison Syndrome. J. Clin. Invest. 59: 255-263, 1977.
55 Dubois, A., Van Eerdewegh, P. and Gardner, J.D. A new method for simultaneous determination of gastric emptying and secretion. In: Proceedings 5th International Symposium on Gastrointestinal Motility. (Van Trappen, ed.). Leuven., 1977, pp.244-247.
54 Shelby, H.T., Gross, L.P., Lichty, P. and Gardner, J.D. Action of cholecystokinin and cholinergic agents on membrane-bound calcium in dispersed pancreatic acinar cells. J. Clin. Invest. 58: 1482-1493, 1976.
53 Brown, E.M., Gardner, J.D. and Aurbach, G.D. Direct determination of ligand interactions with beta-adrenergic receptors on intact turkey erythrocytes: correlation of binding with biological activity. Endocrinology 99: 1369-1376.
52 Batzri, S. and Gardner, J.D. Amino acid transport in isolated rat thymocytes. J. Biol. Chem. 251: 6030-6035, 1976.
51 Christophe, J.P., Frandsen, E.K., Conlon, T.P., Krishna, G. and Gardner, J.D. Action of cholecystokinin, cholinergic agents, and A-23187 on accumulation of guanosine 3':5'-monophosphate in dispersed guinea pig pancreatic acinar cells. J. Biol Chem. 251: 4640-4645, 1976.
50 Robberecht, P., Conlon, T.P. and Gardner, J.D. Interaction of porcine vasoactive intestinal peptide with dispersed pancreatic acinar cells from the guinea pig. Structural requirements for effects of vasoactive intestinal peptide and secretin on cellular adenosine 3':5'-monophosphate. J. Biol. Chem. 251: 4635-4639, 1976.
49 Christophe, J.P., Conlon, T.P. and Gardner, J.D. Interaction of porcine vasoactive intestinal peptide with dispersed pancreatic acinar cells from the guinea pig. Binding of radioiodinated peptide. J. Biol. Chem. 251: 4629-4634, 1976.
48 Gardner, J.D., Conlon, T.P., Fink, M.L. and Bodanszky, M. Interaction of peptides related to secretin with hormone receptors on pancreatic acinar cells. Gastroenterology 71: 965-970, 1976.
47 Olinger, E.J., McCarthy, D.M., Young, R.C. and Gardner, J.D. Hyperhistaminemia and hyperchlorhydria in basophilic granulocytic leukemia. Gastroenterology 71: 667-669, 1976.
46 Christophe, J.P., Conlon, T.P., Robberecht, P. and Gardner, J.D. The specific binding and action of vasoactive intestinal peptide (VIP) on isolated pancreatic acinar cells. In: Stimulus-Secretion Coupling in the Gastrointestinal Tract. (R.M. Case and H. Goebell, eds.). Univ. Park Press, Baltimore, MD., 1976, pp.377-380.
45 Christophe, J.P., Frandsen, E.K., Conlon, T.P., Krishna, G. and Gardner, J.D. Factors Regulating Cyclic GMP Levels in Isolated Pancreatic Acinar Cells. In: Stimulus-Secretion Coupling in the Gastrointestinal Tract. (R.M. Case and H. Goebell, eds.). Univ. Park Press, Baltimore, Md. 1976, pp.233-235.
44 Gardner, J.D., Aurbach, G.D., Spiegel, A.M. and Brown, E.M. Receptor function and ion transport in turkey erythrocytes. Recent Prog. Horm. Res. 32: 567-595, 1976.
43 Aurbach, G.D., Brown, E., Spiegel, A.M. and Gardner, J.D. Beta-adrenergic receptors, cyclic AMP and ion transport in the avian erythrocyte. In: Cell Membrane Receptors for Viruses, Antigens and Antibodies, Polypeptide Hormones and Small Molecules. (R.F. Beers, Jr. and E.G. Bassett, eds.). Proc. 9th Miles Int. Symp., Raven Press, New York, 1976, pp.379-392.
42 Levy, A.G., Widerlite, L. Schwartz, C.J., Dolin, R., Blacklow, N.R., Gardner, J.D., Kimberg, D.V. and Trier, J.S. Jejunal adenylate cyclase activity in human subjects during viral gastroenteritis. Gastroenterology 70: 321-325, 1976.
41 Gardner, J.D., Conlon, T.P. and Adams, T.D. Cyclic AMP in pancreatic acinar cells: Effects of gastrointestinal hormones. Gastroenterology 70: 29-35, 1976.
40 Dolin, R., Levy, A.G., Wyatt, R.G., Thornhill, T.S. and Gardner, J.D. Viral gastroenteritis induced by the Hawaii agent. Am. J. Med. 59: 761-768, 1975.
39 Gardner, J.D. Pancreatic cholera. Editorial. Western J. Med. 123: 309-310, 1975.
38 Gardner, J.D., Conlon, T.P., Klaeveman, H.L., Adams, T.D. and Ondetti, M.A. Action of cholecystokinin and cholinergic agents on calcium transport in isolated pancreatic acinar cells. J. Clin. Invest. 56: 366-375, 1975.
37 Klaeveman, H.L., Conlon, T.P. and Gardner, J.D. Effects of gastrointestinal hormones on adenylate cyclase activity in pancreatic exocrine cells. In: Gastrointestinal Hormones (J.C. Thompson, ed.). Univ. of Texas Press, Austin, 1975, pp.321-344.
36 Klaeveman, H.L., Conlon, T.P., Levy, A.G. and Gardner, J.D. Effects of gastrointestinal hormones on adenylate cyclase activity in human jejunal mucosa. Gastroenterology 68: 667-675, 1975.
35 Kahn, C.R., Levy, A.G., Gardner, J.D., Miller, J.V., Gorden, P. and Schein, P.S. Pancreatic cholera: beneficial effects of treatment with streptozotocin. New Eng. J. Med. 292: 941-945, 1975.
34 Aurbach, G.D., Spiegel, A.M. and Gardner, J.D. β-Adrenergic receptors, cyclic AMP, and ion transport in the avian erythrocyte. In: Advances in Cyclic Nucleotide Research, 5, (G.I. Drummond, P. Greengard and G.A. Robison, eds.). Raven Press, New York, 1975, pp.117-132.
33 Gardner, J.D., Jow, N. and Kiino, D.R. Refractoriness of cation transport in turkey erythrocytes to stimulation by cyclic adenosine 3':5'-monophosphate. J. Biol. Chem. 250: 1176-1185, 1975.
32 Gardner, J.D., Mensh, R.S., Kiino, D.R. and Aurbach, G.D. Effects of β-adrenergic catecholamines on potassium transport in turkey erythrocytes. J. Biol. Chem. 250: 1176-1185, 1975.
31 Gardner, J.D., Kiino, D.R., Jow, N. and Aurbach, G.D. Effects of extracellular cations and ouabain on catecholamine-stimulated sodium and potassium fluxes in turkey erythrocytes. J. Biol. Chem. 250: 1164-1175, 1975.
30 Aurbach, G.D., Bilezikian, J.P. Klaeveman, H.L. and Gardner, J.D. The beta-adrenergic receptor and cyclic AMP-mediated sodium transport in the avian erythrocyte. In: Endocrinology (Taylor, S., ed.). William Heinemann Medical Books, Ltd., London, 1974, pp.343-348.
29 Butler, V.P., Jr., Schmidt, D.H., Watson, J.F. and Gardner, J.D. Production and properties of digoxin-specific antibodies. Ann. N.Y. Acad. Sci. 242: 717-730, 1974.
28 Gardner, J.D., Klaeveman, H.L., Bilezikian, J.P. and Aurbach, G.D. Stimulation of sodium transport in turkey erythrocytes by cyclic 3',5'-AMP. Endocrinology 96: 499-507, 1974.
27 Gardner, J.D., Klaeveman, H.L., Bilezikian, J.P. and Aurbach, G.D. Effects of ouabain on catecholamine-stimulated sodium transport in turkey erythrocytes. J. Biol. Chem. 248: 516-520, 1974.
26 Boyle, J.M. and Gardner, J.D. Sequence of events mediating the effect of cholera toxin on rat thymocytes. J. Clin. Invest. 53: 1149-1158, 1974.
25 Gardner, J.D. and Frantz, C. Effects of cations on ouabain binding by intact human erythrocytes. J. Memb. Biol. 16: 43-64, 1974.
24 Gardner, J.D., Klaeveman, H.L., Bilezikian, J.P. and Aurbach, G.D. Effect of β-adrenergic catecholamines on sodium transport in turkey erythrocytes. J. Biol. Chem. 248: 5590-5597, 1973.
23 Butler, V.P., Jr., Watson, J.F., Schmidt, D.H., Gardner, J.D., Mandel, W.J. and Skelton, C.L. Reversal of the pharmacological and toxic effects of cardiac glycosides by specific antibodies. Pharm. Rev. 25: 239-248, 1973.
22 Gardner, J.D., Kiino, D.R., Swartz, T.J. and Butler, V.P., Jr. Effects of digoxin-specific antibodies on the accumulation and binding of digoxin by human erythrocytes. J. Clin. Invest. 52: 1820-1833, 1973.
21 Gardner, J.D. and Kiino, D.R. Ouabain binding and cation transport in human erythrocytes. J. Clin. Invest. 52: 1845-1851, 1973.
20 Gardner, J.D. and Conlon, T.P. The effects of sodium and potassium on ouabain binding by human erythrocytes. J. Gen. Physiol. 60: 609-629, 1972.
19 Goldfine, I.D., Gardner, J.D. and Neville, D.M., Jr. Insulin action in isolated rat thymocytes. I. Binding of 125I-insulin and stimulation of α-aminoisobutyric acid transport. J. Biol. Chem. 247: 6919-6926, 1972.
18 Hadler, N.M., Gill, J.R., Jr., and Gardner, J.D. Impaired renal tubular secretion of potassium, elevated sweat sodium chloride concentration, and plasma inhibition of erythrocyte sodium outflux as a complication of systemic lupus erythematosus. Arth. Rheum. 15: 515-523, 1972.
17 Gordon, R.S., Jr., Gardner, J.D. and Kinzie, J.L. Low mannitol clearance into cholera stool as evidence against filtration as the source of stool fluid. Gastroenterology 63: 407-412, 1972.
16 Taussig, L.M. and Gardner, J.D. Effects of saliva and plasma from cystic fibrosis patients on membrane transport. Lancet 1: 1367-1369, 1972.
15 Gardner, J.D., Simopoulos, A.P., Lapey, A. and Shibolet, S. Altered membrane sodium transport in Bartter's syndrome. J. Clin. Invest. 51: 1565-1571, 1972.
14 Gardner, J.D., Shibolet, S. and Ginzler, E.R. A two-site model for sodium transport in rabbit erythrocytes. Biochem. Biophys. Res. Comm. 46: 1361-1367, 1972.
13 Gardner, J.D. and Levy, A.G. Transport of dibasic amino acids by human erythrocytes. Metabolism 21: 413-431, 1972.
12 Gardner, J.D., Shibolet, S. and Ginzler, E.R. A two-site model for sodium transport in human erythrocytes. Biochem. Biophys. Res. Comm. 45: 1548-1553, 1971.
11 Shibolet, S. and Gardner, J.D. Effect of temperature on sodium transport in human erythrocytes in vitro. Am. J. Physiol. 221: 1358-1360, 1971.
10 Gardner, J.D., Lapey, A., Simopoulos, A.P. and Bravo, E.L. Abnormal membrane sodium transport in Liddle's syndrome. J. Clin. Invest. 50: 2253-2258, 1971.
9 Lapey, A. and Gardner, J.D. Abnormal erythrocyte sodium transport in cystic fibrosis. Ped. Res. 5: 446-451, 1971.
8 Gardner, J.D. and Lapey, A. Sodium outflux and ATPase activity in human and rabbit erythrocytes. J. Appl. Physiol. 31: 161-163, 1971.
7 Gardner, J.D. and Ginzler, E.R. Sodium transport in human erythrocytes--absence of an effect of prostaglandin E1. Biochem. Biophys. Res. Comm. 42: 1063-1067, 1971.
6 Gardner, J.D., Brown, M.S. and Laster, L. The columnar epithelial cell of the small intestine: Digestion and transport. New Eng. J. Med. 283: 1196-1202, 1264-1271, 1317-1324, 1970.
5 DaCruz, G.M.G., Gardner, J.D. and Peskin, G.W. Mechanism of diarrhea of villous adenomas. Am. J. Surg. 115: 203-208, 1968.
4 DaCruz, G.M.G., Gardner, J.D. and Peskin, G.W. Influence of gastrointestinal tumors on intestinal absorption. Surg. Forum. 18: 336-338, 1967.
3 Gardner, J.D. and Cerda, J.J. In vitro inhibition of intestinal fluid and electrolyte transfer by a non-beta islet cell tumor. Proc. Soc. Exptl. Biol. Med. 123: 361-364, 1966.
2 Gardner, J.D. and Peskin, G.W. Problems in intestinal absorption. Am. J. Med. Sci. 251: 225-235, 1966
1 Gardner, J.D., Peskin, G.W., Cerda, J.J. and Brooks, F.P. Alterations of in vitro fluid and electrolyte absorption by gastrointestinal hormones. Am. J. Surg. 113: 57-64, 1966.

Home . About Us . Case Studies . Clients . Testimonials . Bibliography . Contact Us
© 2006 Science for Organizations . All Rights Reserved